Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand treatment

.Sanofi has brought in an overdue access to the radioligand celebration, paying for one hundred thou...

F 2G raises $100M for 2nd effort to acquire brand new antifungal to market

.After F2G's first attempt to receive a new class of antifungal to market was hindered by the FDA, t...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 systems amidst success pressures

.Moderna has actually pledged to reduce R&ampD investing through $1.1 billion through 2027. The sele...

Sanofi's $80M bank on Fulcrum dystrophy medicine ends in stage 3 go belly up

.Only 4 months after Sanofi bet $80 million in ahead of time money on Fulcrum Therapeutics' losmapim...

Oncternal equity sinks 60% surrounded by discharges, trial firings

.Cancer cells business Oncternal Therapeutics is folding all its clinical tests as well as giving up...

Roche is carrying out hopes that its injectable excessive weight prospect could inevitably illustrate 25% fat burning in late-stage trial

.Roche is actually storing out chances that its own injectable being overweight prospect could inevi...

Novo Nordisk barrages 'outstanding' weight management result for dual-acting dental drug in early trial

.Novo Nordisk has raised the cover on a phase 1 test of its dental amylin as well as GLP-1 receptor ...

AbbVie files a claim against BeiGene over blood cancer medicine secret method

.Merely a few quick full weeks after gaining an FDA Fast Track tag for its investigational BTK degra...

Lilly delivers one-two strike along with 2nd tranche of favorable records on regular blood insulin prospect

.Not long after a good records drop for Eli Lilly's efsitora alfa, the Indianapolis-based provider i...

BridgeBio reduces gene treatment budget plan as scientific information disappoint

.BridgeBio Pharma is slashing its genetics therapy budget plan and also pulling back coming from the...